ASMF vs DMF: Key Differences for Active Pharmaceutical Ingredient Manufacturers

ASMF vs DMF: Key Differences for Active Pharmaceutical Ingredient Manufacturers ASMF vs DMF is an important topic in pharmaceutical regulatory affairs, particularly for Active Pharmaceutical Ingredient (API) manufacturers seeking regulatory approval in different markets. Both the Active Substance Master File (ASMF) and Drug Master File (DMF) contain detailed information about API manufacturing processes, quality, and… Continue reading ASMF vs DMF: Key Differences for Active Pharmaceutical Ingredient Manufacturers

Published
Categorized as Regulatory

Marketing Authorization Application (MAA): A Guide to Regulatory Submission

Marketing Authorization Application (MAA): A Guide to Regulatory Submission A Marketing Authorization Application (MAA) is a key regulatory submission that pharmaceutical companies must prepare to obtain approval to market a medicinal product in a particular country or region. It contains the scientific, clinical, and manufacturing information required by regulatory authorities to assess the quality, safety,… Continue reading Marketing Authorization Application (MAA): A Guide to Regulatory Submission

Published
Categorized as Regulatory

Marketing Authorization Application: A Guide to Regulatory Submission

Marketing Authorization Application: A Guide to Regulatory Submission A marketing authorization application (MAA) is an essential regulatory submission for pharmaceutical companies seeking approval to market a medicinal product in a specific region. It contains the scientific and technical information required by regulatory authorities to assess the product’s quality, safety, and efficacy. Proper preparation and compliance… Continue reading Marketing Authorization Application: A Guide to Regulatory Submission

Published
Categorized as Regulatory

Drug Master File (DMF): Types, Preparation, and Filing Considerations

Drug Master File (DMF): Types, Preparation, and Filing Considerations Drug master file preparation is an important regulatory activity for pharmaceutical companies and manufacturers of drug substances, excipients, and other materials used in pharmaceutical products. A Drug Master File (DMF) contains detailed information about manufacturing processes, facilities, specifications, and quality controls. It enables manufacturers to provide… Continue reading Drug Master File (DMF): Types, Preparation, and Filing Considerations

Published
Categorized as Regulatory

FDA Adopts Super Intelligence (SI) Terminology Across Agency Communications

FDA Adopts Super Intelligence (SI) Terminology Across Agency Communications REGULATORY UPDATE The U.S. Food and Drug Administration (FDA) announced that beginning November 16, 2026, it will use the terms Super Intelligence (SI) and Super Intelligence Systems in newly issued public-facing documents and communications, replacing references to Artificial Intelligence (AI) where applicable.

Published
Categorized as Regulatory

ANDA Submission Process: Key Requirements for Generic Drug Manufacturers

ANDA Submission Process: Key Requirements for Generic Drug Manufacturers The ANDA submission process is a key regulatory pathway for generic drug manufacturers seeking approval from the US Food and Drug Administration (FDA) to market generic versions of approved medicines. An Abbreviated New Drug Application (ANDA) contains information demonstrating that the generic product is pharmaceutically equivalent… Continue reading ANDA Submission Process: Key Requirements for Generic Drug Manufacturers

Published
Categorized as Regulatory

NDA Submission Checklist: Essential Documents for a US FDA Application

NDA Submission Checklist: Essential Documents for a US FDA Application A New Drug Application (NDA) requires pharmaceutical companies to compile comprehensive scientific, clinical, and manufacturing information for submission to the US Food and Drug Administration (FDA). A well-prepared NDA submission checklist helps sponsors organise essential documents, verify submission completeness, and ensure that the application meets… Continue reading NDA Submission Checklist: Essential Documents for a US FDA Application

Published
Categorized as Regulatory

IND Submission Requirements: A Practical Guide for Pharmaceutical Companies

IND Submission Requirements: A Practical Guide for Pharmaceutical Companies IND submission requirements are essential for pharmaceutical companies seeking permission to begin clinical investigations of a new drug candidate in the United States. An Investigational New Drug (IND) application must be submitted to the US Food and Drug Administration (FDA) before a clinical investigation involving human… Continue reading IND Submission Requirements: A Practical Guide for Pharmaceutical Companies

Published
Categorized as Regulatory

What Is a Pharmaceutical Regulatory White Paper? Purpose, Structure, and Preparation

What Is a Pharmaceutical Regulatory White Paper? Purpose, Structure, and Preparation A pharmaceutical regulatory white paper is an informative document that explains regulatory requirements, industry challenges, and compliance-related topics in the pharmaceutical sector. It helps pharmaceutical companies understand the regulatory landscape, evaluate industry developments, and make informed decisions. A well-prepared white paper presents technical information… Continue reading What Is a Pharmaceutical Regulatory White Paper? Purpose, Structure, and Preparation

Published
Categorized as Regulatory

How to Choose a Pharmaceutical Regulatory Affairs Consulting Partner

How to Choose a Pharmaceutical Regulatory Affairs Consulting Partner Choosing the right pharmaceutical regulatory affairs consulting services is important for pharmaceutical companies seeking regulatory compliance, successful product approvals, and effective submission management. An experienced consulting partner can help organisations understand complex regulatory requirements, prepare accurate documentation, and navigate different health authority expectations. Selecting the right… Continue reading How to Choose a Pharmaceutical Regulatory Affairs Consulting Partner

Published
Categorized as Regulatory
Book a Demo